{"@context":{"@vocab":"https://schema.org/"},"@type":"Drug","@id":"https://api.morvs.ai/drug-product/63323-286#drug","name":"Naropin","alternateName":"ROPIVACAINE HYDROCHLORIDE","identifier":[{"@type":"PropertyValue","propertyID":"FDA National Drug Code (NDC)","value":"63323-286"},{"@type":"PropertyValue","propertyID":"FDA application number","value":"NDA020533"},{"@type":"PropertyValue","propertyID":"UNII","value":"V910P86109"},{"@type":"PropertyValue","propertyID":"SPL Set ID","value":"dff4a1e4-4b2a-4a64-b6d8-ea470dee88f7"}],"activeIngredient":"ROPIVACAINE HYDROCHLORIDE","administrationRoute":["EPIDURAL","INFILTRATION","PERINEURAL"],"dosageForm":"INJECTION, SOLUTION","manufacturer":{"@type":"Organization","name":"Fresenius Kabi USA, LLC"},"drugClass":[],"isAvailableGenerically":false,"legalStatus":"HUMAN PRESCRIPTION DRUG","sameAs":["https://api.morvs.ai/drug-approval/NDA020533","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=dff4a1e4-4b2a-4a64-b6d8-ea470dee88f7","https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=63323-286"],"isAccessibleForFree":true,"license":"https://creativecommons.org/publicdomain/zero/1.0/","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://creativecommons.org/publicdomain/zero/1.0/","primary_source":"https://open.fda.gov/apis/drug/ndc/","generated_at":"2026-10-31T06:16:13.049Z"}}